BioPharmaSpec is a global Contract Research Organization (CRO) specializing in the structural and physicochemical characterization of biopharmaceuticals. With locations in the UK, USA, and Europe (Germany, Italy, and Lithuania), we provide expert analytical services to support the biopharmaceutical industry in the development of therapeutic products.

Our expertise spans a wide range of biopharmaceuticals, including biosimilars, monoclonal antibodies, Antibody Drug Conjugates (ADCs), gene therapies (such as AAV-based therapeutics), peptides, oligonucleotides, and recombinant proteins. We focus on the discovery, early, and pre-clinical phases of product development.

BioPharmaSpec's services include primary de novo amino acid sequencing, peptide mapping, impurity analysis, and structural characterization, using advanced techniques such as mass spectrometry, NMR, FTIR, and circular dichroism.

We enable our clients to make informed development decisions based on reliable, high-quality analytical data, ensuring the success and safety of biopharmaceutical products.